BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
Feb 23, 2026
BioNexus Gene Lab Corp. finalized governance restructuring of subsidiary Chemrex Corporation, appointing Matthew Barsing as Chairman to streamline oversight. This move supports disciplined capital allocation and strategic evaluations for potential advanced manufacturing or healthcare initiatives.
Show all 15 updates